If this is what is being written about Woodside (>$34.00) .... then methinks $3.50 plus atm is what HDR is worth.
"Woodside Petroleum’s (WPL) attractiveness as a long term investment option received a firm boost this week due to a company update by the oil and gas experts at Smith Barney Citigroup.
Until recently, the broker valued the shares of Australia’s leading oil explorer and producer at $19.80
a piece. Taking into account the upside from the upcoming drilling program offshore Mauritania, the
broker’s value rose to $21.03.
However, these calculations are based on the broker’s long term WTI spot oil price forecast of US$24 per barrel. Using the current consensus long-term price of US$27.8/bbl would produce a value of $26.05/share. As standard the broker applies a 5% discount to valuation for the company, which would take the target price to $24.75 – still at a 17.5% premium to the current valuation of $21.03.
If the broker were to adopt the current 2004 average price for WTI of US$37.65/bbl as the basis for the calculation (and leave the value of the gas reserves unchanged) the valuation would increase to $34.25 while the target price would rise to $32.50, implying a 54% premium.
Acknowledging that oil is likely to remain higher priced than previously anticipated in the foreseeable future, the analysts have chosen to seek the middle ground, adopting a target price that incorporates a 12.5% premium to their base case valuation. This has resulted in a revised target of $23.65.
Deutsche Bank too thinks the shares should be trading past $20 relatively soon, unless unforeseen circumstances such as renewed political instability in Mauritania play a part."
- Forums
- ASX - By Stock
- HDR
- $2.12 - what a bargain ....
HDR
hardman resources limited
$2.12 - what a bargain ....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online